Amgen Report on Nuzzel

modernhealthcare.com - Pfizer's biosimilar for chemo patients OK'd to vie against Amgen's Neupogen

Pfizer's biosimilar for chemo patients OK'd to vie against Amgen's Neupogen

Modern Healthcare
marketwatch.com - Pfizer gets FDA approval for drug similar to Amgens Neupogen

Pfizer gets FDA approval for drug similar to Amgens Neupogen

MarketWatch
fool.com - George Budwell - Better Buy: Biogen Inc. vs. Amgen

Better Buy: Biogen Inc. vs. Amgen

The Motley Fool – George Budwell
biospace.com - Mark Terry - Amgen and UCB Take Another Shot at Osteoporosis Drug

Amgen and UCB Take Another Shot at Osteoporosis Drug

BioSpace – Mark Terry
pharmaphorum.com - Amgen and UCB re-file Evenity for US approval - Pharmaphorum

Amgen and UCB re-file Evenity for US approval - Pharmaphorum

pharmaphorum.com
worldpharmanews.com - Amgen and MBC Biolabs announce winners of the Amgen Golden Ticket

Amgen and MBC Biolabs announce winners of the Amgen Golden Ticket

worldpharmanews.com
biospace.com - Alex Keown - Could Amgen Eye Alexion as a M&A Target to Offset Neulasta Decline?

Could Amgen Eye Alexion as a M&A Target to Offset Neulasta Decline?

BioSpace – Alex Keown
jdsupra.com - New BPCIA Complaint: Amgen Sues Pfizer over Proposed Filgrastim Biosimilar

New BPCIA Complaint: Amgen Sues Pfizer over Proposed Filgrastim Biosimilar

JD Supra
fool.com - Keith Speights - Better Buy: Amgen Inc. vs. Johnson & Johnson

Better Buy: Amgen Inc. vs. Johnson & Johnson

The Motley Fool – Keith Speights

Top Sources reporting on Amgen

Name
1 americanbankingnews.com
2 EIN News
3 Yahoo
4 JD Supra
5 aktiencheck.de
6 Cyclingnews.com
7 Endpoints News
8 Value Investing
9 02xl